| [1] |
Nephrology Branch of China Association of Chinese Medicine, Nephrology Committee of Guangdong Provincial Association of Chinese Medicine, SU Peiling, YANG Lihong, BAO Kun.
Diagnosis and Treatment Guideline of Integrated Traditional Chinese and Western Medicine for Idiopathic Membranous Nephropathy (2025)
[J]. Chinese General Practice, 2026, 29(15): 1953-1970.
|
| [2] |
YANG Ling, DU Xueping.
Application of Murtagh Safe Diagnostic Strategy Combined with Mind Mapping for Establishing Clinical Thinking in General Practice Teaching Clinic
[J]. Chinese General Practice, 2025, 28(06): 673-680.
|
| [3] |
GAO Ge, ZHANG Xinyue, FENG Yuhua, DOU Jingyu, WU Xueying, CHENG Genyang.
Prognostic Analysis of IgA Nephropathy Patients with High Risk of CKD Progression Treated with Glucocorticoid: a Retrospective Study
[J]. Chinese General Practice, 2024, 27(06): 692-698.
|
| [4] |
ZHANG Kang, ZHAO Tingting, ZHANG Bo, GAO Mengqi, LI Yuxi, WANG Shaopeng, ZHAO Wenjing.
Study on the Mechanism of Budesonide in the Treatment of IgA Nephropathy Based on Network Pharmacology
[J]. Chinese General Practice, 2023, 26(35): 4453-4458.
|
| [5] |
ZHOU Wenjing, SHANG Shili, YANG Qian, FENG Yuerong, LI Jun.
Correlation of Platelet-albumin Ratio with Clinicopathological Features of IgA Nephropathy
[J]. Chinese General Practice, 2023, 26(29): 3657-3664.
|
| [6] |
SUN Shuaigang, SHENG Xiaoxiao, ZHANG Wenhui, TIAN Huijuan, ZHAI Yaling.
The Analysis of Clinicopathological Characters and Short-term Prognosis in Idiopathic Membranous Nephropathy Patients with Immunoglobulin G4 Combined with Other Different Immunoglobulin G Subtypes Deposition
[J]. Chinese General Practice, 2023, 26(21): 2632-2638.
|
| [7] |
YAN Peng, SONG Jianling, FANG Xiangdong.
Recent Developments in Parathyroid Hormone Type 1 Receptor and Kidney Disease
[J]. Chinese General Practice, 2023, 26(11): 1398-1403.
|
| [8] |
Nephrology Branch of China Association of Chinese Medicine, Nephrology Committee of Guangdong Provincial Association of Chinese Medicine, YANG Lihong, SU Peiling, BAO Kun.
Clinical Practice Guideline for Chinese Medicine in the Treatment of Idiopathic Membranous Nephropathy (2021)
[J]. Chinese General Practice, 2023, 26(06): 647-659.
|
| [9] |
Jianghua KE, Shuwei DUAN, Linchang LIU, Shuang LI, Yujing KE, Yilun QU, Jin YAO, Xiangmei CHEN.
Clinical, Pathological and TCM Syndromes of Primary IgA Nephropathy with Malignant Hypertension
[J]. Chinese General Practice, 2022, 25(27): 3395-3403.
|
| [10] |
LIU Tongtong,WANG Yuyang,YANG Liping,MAO Huimin,ZHAN Yongli.
Efficacy and Safety of Different Pharmacological Interventions for Progressive IgA Nephropathy:a Network Meta-analysis
[J]. Chinese General Practice, 2021, 24(8): 989-1000.
|
| [11] |
YU Baisong,LIU Bing.
Advances in the Treatment of Primary IgA Nephropathy
[J]. Chinese General Practice, 2021, 24(23): 2985-2991.
|
| [12] |
.
Effect of Bredinine Combined with Middle Dose Glucocorticoid in the Treatment of IgA Nephropathy
[J]. Chinese General Practice, 2020, 23(6): 667-671.
|
| [13] |
ZHANG Dongliang,LUO Li,ZHENG Liren,HU Nana,WAN Li,YANG Qinghua,ZHANG Zhoucang.
Rituximab Salvage Therapy Is Inappropriate for Secondary Refractory Nephropathy
[J]. Chinese General Practice, 2020, 23(36): 4645-4650.
|
| [14] |
ZHAI Yaling,GAO Jingge,LONG Xiaoqing,LI Ruman,DOU Yanna,LIU Dong,XIAO Jing,ZHAO Zhanzheng,LIU Zhangsuo,CHENG Genyang.
Clinical Significance of Serum a Proliferation-inducing Ligand in Patients with Idiopathic Membranous Nephropathy
[J]. Chinese General Practice, 2020, 23(14): 1764-1768.
|
| [15] |
LIANG Yan,ZHANG Xiaoling,LIU Bing,ZHU Qing,SHAO Fengmin.
Curative Effect of Tripterygium Glycosides Combined with Irbesartan on IgA Nephropathy with Increased Urinary Podocyte Excretion
[J]. Chinese General Practice, 2019, 22(12): 1426-1431.
|